Name | AVANSEPT MEDIKAL, OOO |
|---|
INN | 7715283783 |
|---|
KPP | 774301001 |
|---|
OGRN | 1027739336965 |
|---|
OKPO | 56739504 |
|---|
Address | 125212, G.moskva, ul. Vyborgskaya, d. D. 16, of. POMESCH. XVI KOM. 33 |
|---|
Phone | 514-19-00 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.18.1 | Core activity | Agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents |
Registration date | 08.10.2002 |
|---|
Registering department | Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata |
|---|
|
AVANSEPT MEDIKAL, OOO (Moscow; INN 7715283783) was registered on 8 Oct 2002. The company's authorized capital as of July 1, 2012 was 13200 rub. Type of ownership of AVANSEPT MEDIKAL, OOO - Limited liability companies. Form of ownership of AVANSEPT MEDIKAL, OOO - Private property. Principal activities of AVANSEPT MEDIKAL, OOO: agents specialized in the wholesale trade of pharmaceutical products, products used for medical purposes, perfume and cosmetics, including soap and detergents (46.18.1). |
Economic indicators2023
Net profit (RAS) of AVANSEPT MEDIKAL, OOO made up 5.72 million RUB over 2023 compared to net loss of 385.00 thousand RUB over 2022, the company informed. Revenue decreased in the accounting period by 2.40% to 285.58 million RUB from 292.59 million RUB in 2022; cost of goods sold decreased by 10.76% to 209.96 million RUB from 235.26 million RUB; sales profit made up 10.06 million RUB compared to sales loss of 2.17 million RUB. 2022
Net loss (RA) of AVANSEPT MEDIKAL, OOO made up 385.00 thousand RUB over 2022 compared to net profit of 15.65 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 0.84% to 292.59 million RUB from 295.06 million RUB in 2021; cost of goods sold grew by 1.97% to 235.26 million RUB from 230.72 million RUB; sales loss made up 2.17 million RUB compared to sales profit of 17.83 million RUB. 2021
Net profit (RAS) of AVANSEPT MEDIKAL, OOO grew over 2021 by 18.61% to 15.65 million RUB from 13.19 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 42.07% to 295.06 million RUB from 509.32 million RUB in 2020; cost of goods sold decreased by 45.88% to 230.72 million RUB from 426.34 million RUB; sales profit fell by 12.29% to 17.83 million RUB from 20.33 million RUB. 2020
Net profit (RAS) of AVANSEPT MEDIKAL, OOO made up 13.19 million RUB over 2020 compared to net loss of 204.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period 2.26 times to 509.32 million RUB from 225.51 million RUB over 2019; cost of goods sold grew 2.40 times to 426.34 million RUB from 177.55 million RUB; sales profit went up 15.33 times to 20.33 million RUB from 1.33 million RUB. 2018
Net profit (RAS) of AVANSEPT MEDIKAL, OOO dropped in 2018 by 13.19% to 21.56 million RUB from 24.84 million RUB over the same period in 2017, the company informed. Revenue decreased in the accounting period by 1.91% to 214.74 million RUB from 218.92 million RUB in 2017; cost of goods sold decreased by 3.27% to 162.26 million RUB from 167.75 million RUB; sales profit fell by 17.85% to 26.80 million RUB from 32.62 million RUB. 2017
Net profit (RAS) of AVANSEPT MEDIKAL, OOO grew over 2017 2.48 times to 24.84 million RUB from 10.00 million RUB over 2016, the company informed. Revenue decreased in the accounting period by 7.95% to 218.92 million RUB from 237.82 million RUB in 2016; cost of goods sold decreased by 19.45% to 167.75 million RUB from 208.27 million RUB; sales profit went up 2.65 times to 32.62 million RUB from 12.33 million RUB. 2016
Net profit (RAS) of AVANSEPT MEDIKAL, OOO grew over 2016 by 10.84% to 10.00 million RUB from 9.02 million RUB over 2015, the company informed. Revenue increased in the accounting period by 5.77% to 237.82 million RUB from 224.85 million RUB over 2015; cost of goods sold grew by 6.91% to 208.27 million RUB from 194.81 million RUB; sales profit went up by 1.68% to 12.33 million RUB from 12.13 million RUB. 2014
Net profit (RAS) of AVANSEPT MEDIKAL, OOO grew over 2014 by 37.34% to 18.63 million RUB from 13.56 million RUB over 2013, the company informed. Revenue increased in the accounting period by 30.85% to 189.67 million RUB from 144.95 million RUB over 2013; cost of goods sold grew by 34.13% to 149.44 million RUB from 111.42 million RUB; sales profit went up by 33.55% to 23.72 million RUB from 17.76 million RUB. 2013
Net profit (RAS) of AVANSEPT MEDIKAL, OOO dropped in 2013 by 33.71% to 13.56 million RUB from 20.46 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 3.95% to 144.95 million RUB from 150.91 million RUB in 2012; cost of goods sold decreased by 1.03% to 111.42 million RUB from 112.57 million RUB; sales profit fell by 34.32% to 17.76 million RUB from 27.04 million RUB. 2012
Net profit (RAS) of AVANSEPT MEDIKAL, OOO grew over 2012 1.51 times to 20.46 million RUB from 13.55 million RUB over 2011, the company informed. Revenue increased in the accounting period by 13.76% to 150.91 million RUB from 132.66 million RUB over 2011; cost of goods sold grew by 7.18% to 123.87 million RUB from 115.58 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|